• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Financial Officer Archer Mark

    3/31/25 5:29:59 PM ET
    $LGMK
    Industrial Specialties
    Health Care
    Get the next $LGMK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Archer Mark

    (Last) (First) (Middle)
    2801 DIODE LANE

    (Street)
    LOUISVILLE KY 40299

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    LogicMark, Inc. [ LGMK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    03/27/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Series A Common Stock Purchase Warrant(1) $0.118(1) 03/27/2025(1) A 67,794(1) 10/01/2024 08/05/2029 Common Stock 67,794(1) $0.125 84,742(1) D
    Explanation of Responses:
    1. This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.
    /s/ Mark Archer 03/31/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LGMK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LGMK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LGMK
    SEC Filings

    See more
    • LogicMark Inc. filed SEC Form 8-K: Shareholder Director Nominations

      8-K - LogicMark, Inc. (0001566826) (Filer)

      6/26/25 4:05:28 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - LogicMark, Inc. (0001566826) (Filer)

      6/2/25 8:45:20 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 424B3 filed by LogicMark Inc.

      424B3 - LogicMark, Inc. (0001566826) (Filer)

      5/30/25 4:21:33 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Financial Officer Archer Mark

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:59 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Pettitt John P

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:32 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by President and CEO Simmons Chia-Lin

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:03 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets

      LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care economy, announced the appointment of Jeffrey Durkin, as Senior Vice President of Sales effective June 23, 2025. Mr. Durkin previously held sales and marketing roles with InfoMC, Casenet, InstaMed, HMS, and Allscripts. He holds a Master of Business Administration from Anna Maria College and a Bachelor of Science in Marketing from Fitchburg State University. In his new role, Mr. Durkin will lead the sales team at LogicMark and drive significant growth for the company in the c

      6/17/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives

      LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems ("PERS"), health communication devices, and technology for the growing care economy, today announced that it expects that its common stock will begin trading on the over-the-counter markets ("OTC Markets"), effective today. The move to OTC Markets follows Nasdaq's decision to delist the Company's common stock at the opening of trading today, due solely to the Company's non-compliance with Nasdaq's $1.00 minimum bid price requirement. Chia-Lin Simmons, CEO of LogicMark, emphasized the importance of this transition, stating, "The ability to continue quotation

      6/2/25 8:30:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals

      LOUISVILLE, Ky., April 28, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing care economy, today announced changes to its Board committee assignments. The LogicMark Board of Directors maintains an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. The Board comprises four independent non-executive directors who serve on the Committees and the Company's Chief Executive Officer (CEO), totaling five directors. The following new Board committee assignments reflect LogicMark's ongoing efforts to ensure that it

      4/28/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care